Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
JBIO
JBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JBIO News
HC Wainwright Initiates Buy on Jade Biosciences with $25 Price Target
Jan 07 2026
Benzinga
Jade Biosciences Outlines 2026 Strategic Priorities and Clinical Developments
Jan 05 2026
NASDAQ.COM
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
JBIO Rises More Than 75% in Two Months Due to Pipeline Progress - Did You Invest?
Dec 17 2025
NASDAQ.COM
Jade Biosciences Secures $45 Million Financing from BB Biotech
Dec 15 2025
Globenewswire
Jade Biosciences Secures $45 Million Financing from BB Biotech
Dec 15 2025
Newsfilter
Clear Street Begins Coverage of Jade Biosciences with a Buy Rating and Sets Price Target at $25
Nov 25 2025
Benzinga
Reasons to Consider Jade Biosciences, Inc. (JBIO) as a New Investment Opportunity
Nov 18 2025
NASDAQ.COM
Significant Options Activity on Tuesday: WBD, C, JBIO
Nov 18 2025
NASDAQ.COM
Major Stocks on the Rise Monday: Jazz Pharmaceuticals, Sigma Lithium, Zymeworks, and More
Nov 17 2025
Benzinga
Significant Options Activity on Monday: JBIO, MU, GOOGL
Nov 10 2025
NASDAQ.COM
Jade Biosciences Unveils New Findings Highlighting Positive Preclinical Safety of JADE101 and APRIL-Mediated Biomarker Responses at the 2025 American Society of Nephrology Kidney Week
Nov 08 2025
Yahoo Finance
BTIG Begins Coverage of Jade Biosciences with a Buy Rating and Sets Price Target at $28
Oct 09 2025
Benzinga
Jade Biosciences Unveils JADE201, a Promising Long-Lasting Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Treating Autoimmune Disorders
Oct 07 2025
Newsfilter
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Jul 17 2025
Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
Jul 17 2025
Benzinga
Show More News
